We are on a mission to make you succeed in every step of the cell therapy value chain. Focusing on tomorrow needs and becoming your long-term manufacturing partner is our way to achieve this. We think about your process today and apply our proven agile methodology and tools to ensure sustainable production and commercialisation of your ATMPs & HCT/Ps. Working in a transparent manner and with a particular attention to quality.
The iCone (iPSC-derived Cortical neurons) Consortium made up of MaSTherCell SA (CDMO dedicated to industrialisation and production of Cell and Gene Therapies), Ncardia (a drug discovery and...
GREENWICH, CT and CHARLEROI, BELGIUM - January 25, 2019 - Great Point Partners, LLC (“Great Point”), a Greenwich-based private investment firm focused on the health care industry and MaSTherCell Global, Inc. (“MaSTherCell Global”), a portfolio...
We Help Bring Potent Therapies to Patients
Strong process and technology expertise to develop, industrialize and upscale processes and/or facilitate their GMP translation.
Cell therapy expertise and flexible infrastructure to perform cGMP manufacturing, from technology transfer to product delivery.